SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-21-058530
Filing Date
2021-04-30
Accepted
2021-04-30 11:35:27
Documents
3
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tm2114361d2_10qa.htm 10-Q/A 32053
2 EXHIBIT 31.1 tm2114361d2_ex31-1.htm EX-31.1 8653
3 EXHIBIT 31.2 tm2114361d2_ex31-2.htm EX-31.2 8950
  Complete submission text file 0001104659-21-058530.txt   50663
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38630 | Film No.: 21875189
SIC: 2834 Pharmaceutical Preparations